Neuregulin1beta1 Antagonizes Apoptosis Via ErbB4-Dependent Activation of PI3-Kinase/Akt in APP/PS1 Transgenic Mice
- 640 Downloads
Alzheimer’s disease (AD) is characterized by the deposition of beta-amyloid protein (Aβ) and extensive neuronal cell death. Apoptosis plays a crucial role in loss of neurons in AD. Neuregulin1 (NRG1) has been found to protect neurons from oxygen glucose deprivation induced apoptosis and hypoxia ischemia induced apoptosis. However, the relationship between NRG1 and apoptosis related protein expression in AD and its mechanism remain uncertain. The present study explores the effects of NRG1 on Aβ-induced apoptosis in AD. In this study, extracellular domain of NRG1beta1 (NRG1β1-ECD) promoted the expression of p-ErbB4 receptor, p-Akt and increased the level of Bcl-2 both in APP/PS1 transgenic mice and in vitro. In primary culture of neurons, the level of Bcl-2 protein decreased significantly after Aβ treatment. These changes were inhibited by pretreatment of neurons with NRG1β1-ECD. A specific inhibitor of PI3-kinase/Akt pathway, wortmannin, significantly abrogated the effects of NRG1β1-ECD on p-Akt and Bcl-2 levels. Furthermore, the expression of PI3-kinase/Akt by NRG1β1-ECD was ErbB4-dependent. Our data demonstrated that NRG1β1-ECD might serve as an obvious neuroprotection in AD, and the possible protective mechanism occurs most likely via ErbB4-dependent activation of PI3-kinase/Akt pathway.
KeywordsNeuregulin1 Apoptosis PI3-kinase/Akt pathway ErbB4 Alzheimer’s disease
This work was supported by the Science and Technology Project of Department of Education of Henan Province (No. 13A310862), the Key Research Areas of Xinxiang Medical University (No. ZD2011-28, ZD2011-14), the Doctoral Scientific Research Activation Foundation of Xinxiang Medical University, Natural Science Foundation of Jiangxi Province, China (No. 20114BAB205063), and National Natural Science Foundation of China (No. 81260211). We would also like to express thanks to Professors Guomin Zhou and Zulin Chen for introducing the animal model.
- 1.Selkoe DJ (2001) Alzheimer’s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimer’s Dis (JAD) 3(1):75–80Google Scholar
- 4.Wang DM, Li SQ, Zhu XY, Wang Y, Wu WL, Zhang XJ (2013) Protective effects of hesperidin against amyloid-beta (Abeta) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells. Neurochem Res 38(5):1034–1044PubMedCrossRefGoogle Scholar
- 6.Ferreiro E, Eufrasio A, Pereira C, Oliveira CR, Rego AC (2007) Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. J Alzheimer’s Dis (JAD) 12(3):223–228Google Scholar
- 7.Clementi ME, Pezzotti M, Orsini F, Sampaolese B, Mezzogori D, Grassi C, Giardina B, Misiti F (2006) Alzheimer’s amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35. Biochem Biophys Res Commun 342(1):206–213PubMedCrossRefGoogle Scholar
- 16.Carlsson T, Schindler FR, Hollerhage M, Depboylu C, Arias-Carrion O, Schnurrbusch S, Rosler TW, Wozny W, Schwall GP, Groebe K, Oertel WH, Brundin P, Schrattenholz A, Hoglinger GU (2011) Systemic administration of neuregulin-1beta1 protects dopaminergic neurons in a mouse model of Parkinson’s disease. J Neurochem 117(6):1066–1074PubMedCrossRefGoogle Scholar
- 24.Sala G, Traini S, D’Egidio M, Vianale G, Rossi C, Piccolo E, Lattanzio R, Piantelli M, Tinari N, Natali PG, Muraro R, Iacobelli S (2012) An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. Oncogene 31(10):1275–1286PubMedCrossRefGoogle Scholar
- 28.Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J (2004) Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J Off Publ Fed Am Soc Exp Biol 18(10):1162–1164Google Scholar
- 32.Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13(2):159–170PubMedCrossRefGoogle Scholar
- 35.Tokita Y, Keino H, Matsui F, Aono S, Ishiguro H, Higashiyama S, Oohira A (2001) Regulation of neuregulin expression in the injured rat brain and cultured astrocytes. J Neurosci Off J Soc Neurosci 21(4):1257–1264Google Scholar